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83.3%, respectively, and those for the advanced stage mesothelioma 
were 41.7% and 0%, respectively (p<0.0023).
Conclusions: Histopathologically, there were few cases with stage I 
mesothelioma. Invasion was observed even in extremely early stage 
MPMs in our series. Once MPM develops, mesothelioma cells may 
exfoliate easily into the pleural effusion or extend in lymphatic ves-
sels and disseminate diffusely onto the parietal and visceral pleura, 
thereafter proliferating as in situ neoplasm before invasive nodules are 
formed. Although MPM may ﬁrst develop at some point of parietal 
pleura, it soon invades into both parietal and visceral pleura, dissemi-
nates, proliferates and invades adjacent tissue rapidly. Because MPM 
with stage IA is rarely recognized, it is not practical to categorize stage 
I into stage IA or IB.
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Objective: Thymic carcinomas typically carry a poor prognosis and 
are quite rare. As such, their management has not been standardized. 
We reviewed our recent experience with multimodality treatment for 
thymic carcinoma for outcomes.
Methods: Retrospective review of a single institution surgical data-
base. Data included patient demographics, pre-operative staging and 
treatment, peri-operative events, pathologic ﬁndings, and postoperative 
outcomes.
Results: During the 10 year period from 1996-2006, 115 thymic 
tumors were primarily resected, including 17 patients who had WHO 
2004 Classiﬁcation thymic carcinoma. Patient characteristics are 
listed in the table below. At a mean follow-up of 28.4 months (range 
2.1-141.7, median 10.9), 59% (10/17) are disease-free, 2 have died 
of disease, 4 are alive with disease. Ten patients were able to undergo 
complete resections (59%). There was one operative mortality. There 
were no adverse events of CTCAE Grade III or higher. There have been 
no recurrences in those patients who had complete resections. Median 
survival has not yet been reached. 5-year survival is 80%.
Conclusion: Multimodality therapy in an attempt to attain complete 
resections for thymic carcinoma can result in good long-term survival.
Age (Years) 
Median 63
Range 25-73
Sex 
Male 12
Female 5
Preoperative Chemotherapy 12/17
Carboplatin/Docetaxel 5
Cyclophosphamide/Doxorubicin/Cisplatin 4
Cisplatin/Etoposide 2
Other 1
Additional Resected Structures 
Superior Vena Cava / Innominate Vein 5
Pneumonectomy 1
Postoperative Radiation 9/17
Median Dose (cGy) 5040
Range 3060-6300
Length of Stay (Days) 
Mean 5
Range 3-8
Histology 
Squamous 11
Lymphoepithelioma-like 3
Undiﬀerentiated 1
Mucoepidermoid 1
Adenocarcinoma 1
Masaoka Stage 
I 1
II 4
III 9
IV 3
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Background: The malignant mesothelioma is increasing in Japan, due 
to the import and use of asbestos past 6 decades. However, its accurate 
frequency of mesothelioma is unknown due to different diagnostic 
methods and criteria. The aim of this study is to clarify the accuracy of 
pathological diagnosis of mesothelioma in Japan.
Materials and Methods: Among 878 mesothelioma death cases 
extracted by “Vital Statistics of Japan 2003”, the pathological materi-
als (histological and cytological specimens, parafﬁn blocks etc.) were 
submitted from 204 cases. After these pathological materials were 
